Europe Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others is a new market research publication announced by Reportstack. The report provides key market data on the Europe Drug Delivery Devices market – United Kingdom, Germany, France, Italy and Spain. The report provides value (USD million) data for all the market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.
Scope
- Countries covered include United Kingdom, Germany, France, Italy and Spain.
- Market size and company share data for Drug Delivery Devices market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Baxter International Inc., B. Braun Melsungen AG, CareFusion Corporation, Fresenius Kabi AG, Hospira, Inc., Medtronic, Inc., Smiths Medical and Terumo Corporation.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Companies Mentioned
GlaxoSmithKline plc AstraZeneca PLC Boehringer Ingelheim GmbH Baxter International Inc. B. Braun Melsungen AG CareFusion Corporation Fresenius Kabi AG Hospira, Inc. Medtronic, Inc. Terumo Corporation Smiths Medical Teleflex Incorporated Sunovion Pharmaceuticals Inc. 3M Health Care Ltd. Consort Medical plc Codman & Shurtleff, Inc. JMS Co., Ltd. Edwards Lifesciences Corporation Becton, Dickinson and Company C. R. Bard, Inc. Bioject Medical Technologies Inc. INJEX - Equidyne Systems Antares Pharma, Inc. Cook Medical Incorporated PharmaJet, Inc. Nipro Corporation
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.
Scope
- Countries covered include United Kingdom, Germany, France, Italy and Spain.
- Market size and company share data for Drug Delivery Devices market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Baxter International Inc., B. Braun Melsungen AG, CareFusion Corporation, Fresenius Kabi AG, Hospira, Inc., Medtronic, Inc., Smiths Medical and Terumo Corporation.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Companies Mentioned
GlaxoSmithKline plc AstraZeneca PLC Boehringer Ingelheim GmbH Baxter International Inc. B. Braun Melsungen AG CareFusion Corporation Fresenius Kabi AG Hospira, Inc. Medtronic, Inc. Terumo Corporation Smiths Medical Teleflex Incorporated Sunovion Pharmaceuticals Inc. 3M Health Care Ltd. Consort Medical plc Codman & Shurtleff, Inc. JMS Co., Ltd. Edwards Lifesciences Corporation Becton, Dickinson and Company C. R. Bard, Inc. Bioject Medical Technologies Inc. INJEX - Equidyne Systems Antares Pharma, Inc. Cook Medical Incorporated PharmaJet, Inc. Nipro Corporation
If you purchase this report, you can get free access to any two company profiles and their SWOT analysis from 50,000 company profiles available at Reportstack.
To view the table of contents and know more details please visit Europe Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others.
No comments:
Post a Comment